Profiling the Aspergillus fumigatus proteome in response to caspofungin

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 1, 2011, Pages 146-154

  Cagas, Steven E ^a   Jain, Mohit Raja ^a   Li, Hong ^a   Perlin, David S ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BIOLOGICAL MARKER; CASPOFUNGIN; CYTOTOXIN; FUNGAL PROTEIN; PROTEOME;

ARTICLE; ASPERGILLUS FUMIGATUS; CELL FRACTIONATION; CELL MEMBRANE; CELL WALL; GENE EXPRESSION PROFILING; GENOMICS; ISOBARIC TAGGING FOR RELATIVE AND ABSOLUTE QUANTITATION; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEOMICS; QUANTITATIVE ANALYSIS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; COMPUTATIONAL BIOLOGY; ECHINOCANDINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FUNGAL PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOME;

EID: 78650660144     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00884-10     Document Type: Article

References (44)

1. Antachopoulos, C., J. Meletiadis, T. Sein, E. Roilides, and T. J. Walsh. 2008. Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia. Antimicrob. Agents Chemother. 52:321-328.
2. Arendrup, M. C., G. Garcia-Effron, W. Buzina, K. L. Mortensen, N. Reiter, C. Lundin, H. E. Jensen, C. Lass-Florl, D. S. Perlin, and B. Bruun. 2009. Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing. Antimicrob. Agents Chemother. 53:1185-1193.
3. Asif, A. R., M. Oellerich, V. W. Amstrong, B. Riemenschneider, M. Monod, and U. Reichard. 2006. Proteome of conidial surface associated proteins of Aspergillus fumigatus reflecting potential vaccine candidates and allergens. J. Proteome Res. 5:954-962.
4. Beranova-Giorgianni, S. 2003. Proteome analysis by two-dimensional gel electrophoresis and mass spectrometry: strengths and limitations. Trends Analyt. Chem. 22:273-281.
5. Brajtburg, J., and J. Bolard. 1996. Carrier effects on biological activity of amphotericin B. Clin. Microbiol. Rev. 9:512-531.
6. Cappelletty, D., and K. Eiselstein-McKitrick. 2007. The echinocandins. Pharmacotherapy 27:369-388.
7. Chaudhary, N., J. F. Staab, and K. A. Marr. 2010. Healthy human T-cell responses to Aspergillus fumigatus antigens. PLoS One 5:e9036.
8. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, approved standard, 2nd ed., M38-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
9. da Silva Ferreira, M. E., M. R. Kress, M. Savoldi, M. H. Goldman, A. Hartl, T. Heinekamp, A. A. Brakhage, and G. H. Goldman. 2006. The akuB(KU80) mutant deficient for nonhomologous end joining is a powerful tool for analyzing pathogenicity in Aspergillus fumigatus. Eukaryot. Cell 5:207-211.
10. da Silva Ferreira, M. E., I. Malavazi, M. Savoldi, A. A. Brakhage, M. H. Goldman, H. S. Kim, W. C. Nierman, and G. H. Goldman. 2006. Transcriptome analysis of Aspergillus fumigatus exposed to voriconazole. Curr. Genet. 50:32-44.
11. Denikus, N., F. Orfaniotou, G. Wulf, P. F. Lehmann, M. Monod, and U. Reichard. 2005. Fungal antigens expressed during invasive aspergillosis. Infect. Immun. 73:4704-4713.
12. Denning, D. W. 1998. Invasive aspergillosis. Clin. Infect. Dis. 26:781-803.
13. Diekema, D. J., S. A. Messer, R. J. Hollis, R. N. Jones, and M. A. Pfaller. 2003. Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. J. Clin. Microbiol. 41:3623-3626.
14. Gardiner, R. E., P. Souteropoulos, S. Park, and D. S. Perlin. 2005. Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin. Med. Mycol. 43(Suppl. 1):S299-S305.
15. Gautam, P., J. Shankar, T. Madan, R. Sirdeshmukh, C. S. Sundaram, W. N. Gade, S. F. Basir, and P. U. Sarma. 2008. Proteomic and transcriptomic analysis of Aspergillus fumigatus on exposure to amphotericin B. Antimicrob. Agents Chemother. 52:4220-4227.
16. Gautam, P., C. S. Sundaram, T. Madan, W. N. Gade, A. Shah, R. Sirdeshmukh, and P. U. Sarma. 2007. Identification of novel allergens of Aspergillus fumigatus using immunoproteomics approach. Clin. Exp. Allergy 37:1239-1249.
17. Herbrecht, R., D. W. Denning, T. F. Patterson, J. E. Bennett, R. E. Greene, J. W. Oestmann, W. V. Kern, K. A. Marr, P. Ribaud, O. Lortholary, R. Sylvester, R. H. Rubin, J. R. Wingard, P. Stark, C. Durand, D. Caillot, E. Thiel, P. H. Chandrasekar, M. R. Hodges, H. T. Schlamm, P. F. Troke, and B. de Pauw. 2002. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N. Engl. J. Med. 347:408-415. (Pubitemid 34851833)
18. Howard, S. J., D. Cerar, M. J. Anderson, A. Albarrag, M. C. Fisher, A. C. Pasqualotto, M. Laverdiere, M. C. Arendrup, D. S. Perlin, and D. W. Denning. 2009. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg. Infect. Dis. 15:1068-1076.
19. Jain, M. R., S. Bian, T. Liu, J. Hu, S. Elkabes, and H. Li. 2009. Altered proteolytic events in experimental autoimmune encephalomyelitis discovered by iTRAQ shotgun proteomics analysis of spinal cord. Proteome Sci. 7:25.
20. Kahn, J. N., M. J. Hsu, F. Racine, R. Giacobbe, and M. Motyl. 2006. Caspofungin susceptibility in Aspergillus and non-Aspergillus molds: inhibition of glucan synthase and reduction of beta-D-1,3 glucan levels in culture. Antimicrob. Agents Chemother. 50:2214-2216.
21. Keller, A., A. I. Nesvizhskii, E. Kolker, and R. Aebersold. 2002. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 74:5383-5392.
22. Kniemeyer, O., F. Lessing, and A. A. Brakhage. 2009. Proteome analysis for pathogenicity and new diagnostic markers for Aspergillus fumigatus. Med. Mycol. 47(Suppl. 1):S248-S254.
23. Kniemeyer, O., F. Lessing, O. Scheibner, C. Hertweck, and A. A. Brakhage. 2006. Optimisation of a 2-D gel electrophoresis protocol for the humanpathogenic fungus Aspergillus fumigatus. Curr. Genet. 49:178-189.
24. Latge, J. P. 1999. Aspergillus fumigatus and aspergillosis. Clin. Microbiol. Rev. 12:310-350.
25. Lessing, F., O. Kniemeyer, I. Wozniok, J. Loeffler, O. Kurzai, A. Haertl, and A. A. Brakhage. 2007. The Aspergillus fumigatus transcriptional regulator AfYap1 represents the major regulator for defense against reactive oxygen intermediates but is dispensable for pathogenicity in an intranasal mouse infection model. Eukaryot. Cell 6:2290-2302.
26. Lopez-Medrano, R., M. C. Ovejero, J. A. Calera, P. Puente, and F. Leal. 1995. Aspergillus fumigatus antigens. Microbiology 141(Pt. 10):2699-2704.
27. Maertens, J., I. Raad, G. Petrikkos, M. Boogaerts, D. Selleslag, F. B. Petersen, C. A. Sable, N. A. Kartsonis, A. Ngai, A. Taylor, T. F. Patterson, D. W. Denning, and T. J. Walsh. 2004. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin. Infect. Dis. 39:1563-1571.
28. Nesvizhskii, A. I., A. Keller, E. Kolker, and R. Aebersold. 2003. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75:4646-4658.
29. Nierman, W. C., A. Pain, M. J. Anderson, J. R. Wortman, H. S. Kim, J. Arroyo, M. Berriman, K. Abe, D. B. Archer, C. Bermejo, J. Bennett, P. Bowyer, D. Chen, M. Collins, R. Coulsen, R. Davies, P. S. Dyer, M. Farman, N. Fedorova, T. V. Feldblyum, R. Fischer, N. Fosker, A. Fraser, J. L. Garcia, M. J. Garcia, A. Goble, G. H. Goldman, K. Gomi, S. Griffith-Jones, R. Gwilliam, B. Haas, H. Haas, D. Harris, H. Horiuchi, J. Huang, S. Humphray, J. Jimenez, N. Keller, H. Khouri, K. Kitamoto, T. Kobayashi, S. Konzack, R. Kulkarni, T. Kumagai, A. Lafon, J. P. Latge, W. Li, A. Lord, C. Lu, W. H. Majoros, G. S. May, B. L. Miller, Y. Mohamoud, M. Molina, M. Monod, I. Mouyna, S. Mulligan, L. Murphy, S. O'Neil, I. Paulsen, M. A. Penalva, M. Pertea, C. Price, B. L. Pritchard, M. A. Quail, E. Rabbinowitsch, N. Rawlins, M. A. Rajandream, U. Reichard, H. Renauld, G. D. Robson, S. Rodriguez de Cordoba, J. M. Rodriguez-Pena, C. M. Ronning, S. Rutter, S. L. Salzberg, M. Sanchez, J. C. Sanchez-Ferrero, D. Saunders, K. Seeger, R. Squares, S. Squares, M. Takeuchi, F. Tekaia, G. Turner, C. R. Vazquez de Aldana, J. Weidman, O. White, J. Woodward, J. H. Yu, C. Fraser, J. E. Galagan, K. Asai, M. Machida, N. Hall, B. Barrell, and D. W. Denning. 2005. Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature 438:1151-1156.
30. Perlin, D. S. 2009. Antifungal drug resistance: do molecular methods provide a way forward? Curr. Opin. Infect. Dis. 22:568-573.
31. Pfaller, M. A., L. Boyken, R. J. Hollis, J. Kroeger, S. A. Messer, S. Tendolkar, and D. J. Diekema. 2009. In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-tohead comparison using the CLSI M38-A2 broth microdilution method. J. Clin. Microbiol. 47:3323-3325.
32. Pham, T. K., and P. C. Wright. 2008. The proteomic response of Saccharomyces cerevisiae in very high glucose conditions with amino acid supplementation. J. Proteome Res. 7:4766-4774.
33. Rocha, E. M., G. Garcia-Effron, S. Park, and D. S. Perlin. 2007. A Ser678Pro substitution in Fks1p confers resistance to echinocandin drugs in Aspergillus fumigatus. Antimicrob. Agents Chemother. 51:4174-4176.
34. Ross, P. L., Y. N. Huang, J. N. Marchese, B. Williamson, K. Parker, S. Hattan, N. Khainovski, S. Pillai, S. Dey, S. Daniels, S. Purkayastha, P. Juhasz, S. Martin, M. Bartlet-Jones, F. He, A. Jacobson, and D. J. Pappin. 2004. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 3:1154-1169.
35. Ruppen, I., L. Grau, E. Orenes-Pinero, K. Ashman, M. Gil, F. Algaba, J. Bellmunt, and M. Sanchez-Carbayo. 2010. Differential protein expression profiling by iTRAQ-two-dimensional LC-MS/MS of human bladder cancer EJ138 cells transfected with the metastasis suppressor KiSS-1 gene. Mol. Cell. Proteomics 9:2276-2291.
36. Saeed, A. I., V. Sharov, J. White, J. Li, W. Liang, N. Bhagabati, J. Braisted, M. Klapa, T. Currier, M. Thiagarajan, A. Sturn, M. Snuffin, A. Rezantsev, D. Popov, A. Ryltsov, E. Kostukovich, I. Borisovsky, Z. Liu, A. Vinsavich, V. Trush, and J. Quackenbush. 2003. TM4: a free, opensource system for microarray data management and analysis. Biotechniques 34:374-378.
37. Schrettl, M., H. S. Kim, M. Eisendle, C. Kragl, W. C. Nierman, T. Heinekamp, E. R. Werner, I. Jacobsen, P. Illmer, H. Yi, A. A. Brakhage, and H. Haas. 2008. SreA-mediated iron regulation in Aspergillus fumigatus. Mol. Microbiol. 70:27-43.
38. 2. J. Proteome Res. 9:1985-1994.
39. Stevens, D. A., M. Ichinomiya, Y. Koshi, and H. Horiuchi. 2006. Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin. Antimicrob. Agents Chemother. 50:3160-3161.
40. Sugui, J. A., H. S. Kim, K. A. Zarember, Y. C. Chang, J. I. Gallin, W. C. Nierman, and K. J. Kwon-Chung. 2008. Genes differentially expressed in conidia and hyphae of Aspergillus fumigatus upon exposure to human neutrophils. PLoS One 3:e2655.
41. Taib, M., J. W. Pinney, D. R. Westhead, K. J. McDowall, and D. J. Adams. 2005. Differential expression and extent of fungal/plant and fungal/bacterial chitinases of Aspergillus fumigatus. Arch. Microbiol. 184:78-81.
42. Taylor, R. D., A. Saparno, B. Blackwell, V. Anoop, S. Gleddie, N. A. Tinker, and L. J. Harris. 2008. Proteomic analyses of Fusarium graminearum grown under mycotoxin-inducing conditions. Proteomics 8:2256-2265.
43. Vodisch, M., D. Albrecht, F. Lessing, A. D. Schmidt, R. Winkler, R. Guthke, A. A. Brakhage, and O. Kniemeyer. 2009. Two-dimensional proteome reference maps for the human pathogenic filamentous fungus Aspergillus fumigatus. Proteomics 9:1407-1415.
44. Zieske, L. R. 2006. A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies. J. Exp. Bot. 57:1501-1508.